Starting in March, Bielefeld University will be coordinating the new German Network for Bioinformatics Infrastructure   

In March, Bielefeld University’s Center for Biotechnology (CeBiTec) will be heading a new bioinformatics programme. The Federal Ministry of Education and Research (BMBF) is providing a total of 22 million Euro of funding until 2020 for the German Network for Bioinformatics Infrastructure (de.NBI). The network is bringing together eight German centres that specialize in processing bioinformatics data from the life sciences. As a joint institution, they will offer bioinformatics services for research projects in biotechnology and biomedicine. In addition, the network will train researchers in how to use bioinformatics software.[Weiterlesen]

Chemists at Bielefeld University develop anti-tumour agent  

Chemists at Bielefeld University have developed a molecule containing copper that binds specifically with DNA and prevents the spread of cancer. First results show that it kills the cancer cells more quickly than cisplatin – a widely used anti-cancer drug that is frequently administered in chemotherapy. When developing the anti-tumour agent, Professor Dr. Thorsten Glaser and his team cooperated with biochemists and physicists. The design of the new agent is basic research. ‘How and whether the copper complex will actually be given to cancer patients is something that medical research will have to determine in the years to come,’ says the chemist.[Weiterlesen]